Lpl Financial LLC Sangamo Therapeutics, Inc Transaction History

Lpl Financial LLC

  • $238 Billion
  • Q4 2024

A detailed history of Lpl Financial LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Lpl Financial LLC holds 31,031 shares of SGMO stock, worth $26,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,031
Previous 14,533 113.52%
Holding current value
$26,996
Previous $12,000 158.33%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$0.78 - $2.87 $12,868 - $47,349
16,498 Added 113.52%
31,031 $31,000
Q2 2024

Aug 07, 2024
BUY
$0.36 - $0.65 $1,151 - $2,079
3,199 Added 28.22%
14,533 $5,000
Q1 2024

May 10, 2024
BUY
$0.42 - $1.38 $4,760 - $15,640
11,334 New
11,334 $7,000
Q3 2022

Nov 14, 2022
BUY
$4.27 - $6.39 $45,565 - $68,187
10,671 New
10,671 $52,000
Q1 2022

May 16, 2022
SELL
$5.23 - $7.82 $60,134 - $89,914
-11,498 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$7.29 - $10.97 $10,169 - $15,303
-1,395 Reduced 10.82%
11,498 $86,000
Q3 2021

Nov 15, 2021
SELL
$9.01 - $12.01 $19,209 - $25,605
-2,132 Reduced 14.19%
12,893 $116,000
Q2 2021

Aug 13, 2021
BUY
$10.17 - $12.64 $30,072 - $37,376
2,957 Added 24.5%
15,025 $180,000
Q1 2021

May 14, 2021
SELL
$10.88 - $17.05 $88,639 - $138,906
-8,147 Reduced 40.3%
12,068 $151,000
Q4 2020

Feb 12, 2021
SELL
$9.23 - $18.18 $20,213 - $39,814
-2,190 Reduced 9.77%
20,215 $315,000
Q3 2020

Nov 09, 2020
BUY
$9.38 - $12.48 $79,720 - $106,067
8,499 Added 61.12%
22,405 $212,000
Q2 2020

Aug 13, 2020
BUY
$6.21 - $11.83 $11,799 - $22,477
1,900 Added 15.83%
13,906 $125,000
Q1 2020

May 14, 2020
BUY
$5.05 - $8.85 $5,206 - $9,124
1,031 Added 9.39%
12,006 $76,000
Q4 2019

Feb 14, 2020
SELL
$8.03 - $11.7 $37,339 - $54,405
-4,650 Reduced 29.76%
10,975 $92,000
Q3 2019

Nov 13, 2019
BUY
$9.05 - $12.22 $28,960 - $39,104
3,200 Added 25.75%
15,625 $141,000
Q2 2019

Aug 09, 2019
SELL
$8.75 - $13.03 $6,125 - $9,121
-700 Reduced 5.33%
12,425 $134,000
Q1 2019

May 08, 2019
SELL
$7.72 - $12.81 $25,591 - $42,465
-3,315 Reduced 20.16%
13,125 $125,000
Q4 2018

Feb 07, 2019
BUY
$9.51 - $16.6 $7,988 - $13,944
840 Added 5.38%
16,440 $189,000
Q3 2018

Nov 14, 2018
BUY
$13.05 - $19.05 $62,640 - $91,440
4,800 Added 44.44%
15,600 $264,000
Q2 2018

Aug 14, 2018
BUY
$13.9 - $19.8 $150,120 - $213,840
10,800 New
10,800 $153,000

Others Institutions Holding SGMO

# of Institutions
141
Shares Held
60.4M
Call Options Held
1.46M
Put Options Held
1.84M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $136M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email